Clinical Trial Update: SIB in Upper Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SIB in upper thoracic esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• SIB

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN